Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 4:02 pm Sale | 2025-03-31 | 13G | AtriCure, Inc. ATRC | Champlain Investment Partners, LLC | 2,137,963 4.400% | -652,795 (-23.39%) | Filing History |
| 2025-02-14 08:00 am Purchase | 2024-12-31 | 13G | AtriCure, Inc. ATRC | Hood River Capital Management LLC | 2,923,731 6.000% | 93,131 (+3.29%) | Filing History |
| 2024-11-14 08:00 am Purchase | 2024-09-30 | 13G | AtriCure, Inc. ATRC | Hood River Capital Management LLC | 2,830,600 5.810% | 2,830,600 (New Position) | Filing History |
| 2024-11-12 10:24 am Purchase | 2024-09-30 | 13G | AtriCure, Inc. ATRC | Champlain Investment Partners, LLC | 2,790,758 5.700% | 2,790,758 (New Position) | Filing History |
| 2024-02-14 2:56 pm Sale | 2024-02-14 | 13G | AtriCure, Inc. ATRC | ALLIANCEBERNSTEIN L.P. | 3,371,119 7.200% | -172,771 (-4.88%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | AtriCure, Inc. ATRC | The Vanguard Group | 4,766,029 10.060% | 20,058 (+0.42%) | Filing History |
| 2024-02-01 3:58 pm Sale | 2024-02-01 | 13G | AtriCure, Inc. ATRC | Invesco Ltd. IVZ | 1,162,050 2.500% | -2,205,274 (-65.49%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | AtriCure, Inc. ATRC | BlackRock Inc. BLK | 4,193,887 8.800% | 458,121 (+12.26%) | Filing History |
| 2023-12-08 4:16 pm Purchase | 2023-11-30 | 13G | AtriCure, Inc. ATRC | The Vanguard Group | 4,745,971 10.010% | 356,156 (+8.11%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | AtriCure, Inc. ATRC | Alger Associates, Inc. | 1,755,398 3.800% | -1,485,449 (-45.84%) | Filing History |
| 2023-02-13 7:08 pm Purchase | 2023-02-14 | 13G | AtriCure, Inc. ATRC | ALLIANCEBERNSTEIN L.P. | 3,543,890 7.700% | 112,214 (+3.27%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | AtriCure, Inc. ATRC | The Vanguard Group | 4,389,815 9.440% | 155,517 (+3.67%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | AtriCure, Inc. ATRC | BlackRock Inc. BLK | 3,735,766 8.000% | 21,075 (+0.57%) | Filing History |
| 2023-02-03 1:00 pm Purchase | 2023-02-02 | 13G | AtriCure, Inc. ATRC | Invesco Ltd. IVZ | 3,367,324 7.200% | 929,707 (+38.14%) | Filing History |
| 2022-02-14 4:07 pm Purchase | 2021-12-31 | 13G | AtriCure, Inc. ATRC | Alger Associates, Inc. | 3,240,847 7.100% | 380,325 (+13.30%) | Filing History |
| 2022-02-14 3:57 pm Purchase | 2022-02-14 | 13G | AtriCure, Inc. ATRC | ALLIANCEBERNSTEIN L.P. | 3,431,676 7.500% | 3,431,676 (New Position) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | AtriCure, Inc. ATRC | T. Rowe Price Associates, Inc. | 1,945,751 4.200% | -385,682 (-16.54%) | Filing History |
| 2022-02-09 4:10 pm Purchase | 2022-02-04 | 13G | AtriCure, Inc. ATRC | Invesco Ltd. IVZ | 2,437,617 5.300% | 185,479 (+8.24%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | AtriCure, Inc. ATRC | The Vanguard Group | 4,234,298 9.220% | 1,813,831 (+74.94%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | AtriCure, Inc. ATRC | BlackRock Inc. BLK | 3,714,691 8.100% | -47,907 (-1.27%) | Filing History |